EQR vs EXAS · P/E 26, $26.37B cap vs rev $2.76B
Equity Residential (EQR) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Equity Residential (EQR) is a reit - residential company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
EQR does not have a complete income-statement cache yet.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
EQR currently screens at market cap $26.37B and trailing P/E 25.7. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the EQR and EXAS stock pages for the full models.
Not investment advice.